As genome editing moves from the lab into the clinic, the ethical debate can no longer be hypothetical
The technique should not increase social injustice or division, say bioethicists. Image: REUTERS/National Human Genome Research Institute
Get involved with our crowdsourced digital platform to deliver impact at scale
Stay up to date:
Biotechnology
Don't miss any update on this topic
Create a free account and access your personalized content collection with our latest publications and analyses.
License and Republishing
World Economic Forum articles may be republished in accordance with the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Public License, and in accordance with our Terms of Use.
The views expressed in this article are those of the author alone and not the World Economic Forum.
Related topics:
The Agenda Weekly
A weekly update of the most important issues driving the global agenda
You can unsubscribe at any time using the link in our emails. For more details, review our privacy policy.
More on BiotechnologySee all
Anna Fleck
April 26, 2023
Valeria D’Amico
April 11, 2023
Andrea Merchak
March 3, 2023
Pattra Chun-On and Jonathan Alder
November 23, 2022
Gabriele Lignani and Dimitri Kullmann
November 18, 2022